Recent Headlines
Within Pharmaceuticals
At USEReady’s Dallas Breakfast with Agents Session, Executives Say AI Success Starts with Strategy, Not Software
Leaders from USEReady, HF Sinclair, US LBM, Columbia University and Sigma Computing made the case that quick wins and a unified data foundation have to be built together. - October 20, 2026 - USEReady
Parvus Therapeutics Announces FDA Clearance of Investigational New Drug Application for PVT201
FDA Clearance of Investigational New Drug Application for PVT201, in development for the treatment of autoimmune liver disease and prevention of organ transplant rejection, is the first candidate from the Parvus nanomedicine immune tolerance platform to clear an IND. - October 19, 2026 - Parvus Therapeutics U.S., Inc.
NuuVive Peptides Study Finds 1 in 7 Online Peptide Lab Reports Gives Buyers No Way to Check It With the Lab
A NuuVive Peptides study of 13,923 lab reports posted by 129 online peptide stores finds that a third have no link to the lab's own record, about 1 in 7 gives buyers no way to check it with the lab at all, and the typical report is five months old. - October 16, 2026 - NuuVive Peptides
Nadrich Accident Injury Lawyers Supports California’s Proposed Quartz Countertop Ban to Protect Workers
Nadrich Accident Injury Lawyers supports California’s proposed ban on the manufacture and fabrication of artificial stone containing more than 1% crystalline silica. Founder and Managing Attorney Jeffrey Nadrich says the measure could help protect countertop workers from silicosis, a serious and often fatal occupational lung disease linked to silica dust exposure. - October 15, 2026 - Nadrich Accident Injury Lawyers
Microvascular Therapeutics Selected to Present Investment Opportunity at ACQUICON 2026
Microvascular Therapeutics, Inc. (“MVT”), a clinical-stage biotechnology company developing next-generation ultrasound imaging and therapeutic technologies, today announced that it has been selected to present in the ACQUICON 2026 Deal Room on Tuesday, October 20, 2026, from 12:30–1:30 p.m. Mountain Time at the Karen Gail Miller Conference Center in Salt Lake City. - October 14, 2026 - Microvascular Therapeutics, Inc.
Advantage Healthcare Services Launches ACE, a Provider Education Initiative to Close Gaps in Behavioral Health Treatment Adherence
Advantage Healthcare Services announced the launch of ACE (Advantage Clinical Education™), a provider education initiative designed to help behavioral health care teams address treatment adherence challenges. The inaugural program explores strategies to reduce relapse risk, improve continuity of care, and support better outcomes for individuals living with bipolar disorder and schizophrenia through practical education and companion resources. - October 13, 2026 - Advantage Healthcare Services
On Indigenous Peoples’ Day, Roll With Paid. Expands Tribal Relations Practice
On Indigenous Peoples’ Day, Minnesota payroll and employer-of-record company Roll With Paid. is expanding its tribal relations practice under Managing Member Jen Williams, a member of the Sisseton-Wahpeton Oyate. The practice serves tribally chartered enterprises and Indigenous-owned businesses that work across tribal, state and federal employment requirements, and the company continues to support the work of ICIA, a national Indigenous business and policy association. - October 12, 2026 - Roll With Paid.
AI Can Answer Your Questions. But Can It Truly Understand You? BYOU Brings Humans Back.
As millions turn to AI for emotional support, BYOU Wellbeing is bringing real human connection back. Its free Help Request feature allows people to anonymously share personal struggles and receive different perspectives from wellbeing professionals worldwide. From mental health and relationships to personal growth, BYOU challenges the idea that algorithms alone can replace human understanding, empathy and professional experience. - October 11, 2026 - BYOU Impact Foundation
USEReady Announces Migrate2Quick to Accelerate Legacy BI Migration to Amazon Quick
Expanded approach combines AWS Transform and USEReady’s MigratorIQ agentic platform to help enterprises bring legacy BI, business logic, and governed metrics into an AI-powered decision environment. - October 08, 2026 - USEReady
CJC-1295 + Ipamorelin with DAC vs. No DAC: Kylo Peptides Clarifies Labeling Across Its Research Catalog
Kylo Peptides clarifies CJC-1295 + Ipamorelin labeling so researchers can tell CJC-1295 with DAC from the no-DAC form, Mod GRF 1-29, in its catalog. - October 07, 2026 - Kylo Research Labs LLC
Thandie Wellness Launches to Redefine Early Perimenopause for Millennial Women
A pharmacist-founded wellness brand introduces science-backed supplements and much-needed conversation around one of women's most overlooked life stages. Thandie Wellness, a pharmacist-founded wellness company headquartered in New York, NY, announced the launch of its inaugural line of supplements... - October 07, 2026 - Thandie Wellness
Microvascular Therapeutics to Present Phase II CardiSon™ Data at 40th International Bubble Conference in Chicago
Next-generation ultrasound enhancing agent demonstrated improved left ventricular opacification and significantly reduced acoustic shadowing - October 02, 2026 - Microvascular Therapeutics, Inc.
ALS TDI to Convene ALS Research, Industry, and Community Leaders at 2026 Summit and White Coat Affair Gala
This October, two Boston events will bring people together to share research updates, build connections, and accelerate progress for people with ALS. - September 23, 2026 - ALS Therapy Development Institute
USEReady Joins OpenAI Partner Network to Accelerate Enterprise AI Adoption
Combining production-grade GenAI and Agentic AI expertise with OpenAI technology to help enterprises move from AI experimentation to measurable business impact. - September 23, 2026 - USEReady
Bringing Surgery Where It Is Needed Most: A Webinar Conversation with Dr. William Rhodes and African Mission Healthcare
The October 3 conversation will explore a vision to train African surgeons for underserved communities and strengthen the hospitals where they will serve, with early candidates connected to the Democratic Republic of Congo and Sudan’s Nuba Mountains. - September 22, 2026 - African Mission Healthcare
Zalud Announces Bilingual Telehealth Services Now Available in Texas
Zalud is a Spanish-first telehealth platform founded by Latino physicians Dr. Emill Sanchez and Dr. Joanna Kingsley Tavárez to make healthcare more accessible to Latino communities in Texas and Florida. It offers affordable, no-appointment online care for common non-emergency conditions, women's health concerns, and STIs, along with at-home testing kits. - September 18, 2026 - Zalud Health
Zalud Announces Bilingual Telehealth Services Now Available in Florida
Zalud is a Spanish-first telehealth platform founded by Latino physicians Dr. Emill Sanchez and Dr. Joanna Kingsley Tavárez to make healthcare more accessible to Latino communities in Texas and Florida. It offers affordable, no-appointment online care for common non-emergency conditions, women's health concerns, and STIs, along with at-home testing kits. - September 18, 2026 - Zalud Health
SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease
SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. - September 18, 2026 - SignaBlok, Inc.
Rob Merrill Named CEO of TFives, Life Sciences AI Compliance
TFives appoints 25-year healthcare regulatory veteran as CEO to lead enterprise adoption of compliance-ready AI governance for the Life Sciences industry. - September 17, 2026 - TFives
USEReady Brings SemaBridge to Snowflake as Enterprises Move AI Agents Into Production
The offering gives Snowflake customers a governed semantic foundation to ground AI agent answers in trusted business logic - September 17, 2026 - USEReady
Mindglobal Publishes Enterprise Guide to Wireless Expense Management, Addressing the Gap Between Software Visibility and Cost Recovery
Mindglobal, highly rated on Gartner Peer Insights, today published a new enterprise resource examining how wireless expense management actually works at scale — and why software alone is not sufficient for organizations managing hundreds or thousands of mobile lines. The article, "How Enterprise Wireless Expense Management Works When Software Alone Isn't Enough," is available on their website. - September 17, 2026 - Mindglobal
International Society of Medical AI Brings Global Medical AI Leaders to Florence for ISMAI 2026
The International Society of Medical AI will convene global experts in Florence on 3-4 December for ISMAI 2026, its flagship scientific meeting on evidence, patient safety, clinical judgement, ethics and governance in medical AI. - September 17, 2026 - International Society of Medical AI
Microvascular Therapeutics Appoints George Kokke to Board of Directors
Veteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience. - September 17, 2026 - Microvascular Therapeutics, Inc.
The Rare Cancer That Can Return Decades Later Brings Patients Together to Launch the Solitary Fibrous Tumor Foundation
The Solitary Fibrous Tumor Foundation (SFTF) today announced its launch as the first patient- and supporter-led nonprofit organization dedicated entirely to Solitary Fibrous Tumor (SFT), an ultra-rare sarcoma.The announcement comes during Sarcoma Awareness Month, observed globally each July. SFT... - September 17, 2026 - Solitary Fibrous Tumor Foundation
Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board
Dr Charles Garrison, an experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development as new Scientific Advisory Board member. - September 14, 2026 - Microvascular Therapeutics, Inc.
MVT Nanobubbles Enable Non-Thermal Focused Ultrasound Ablation in Preclinical Brain Tumor Study
University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location - September 14, 2026 - Microvascular Therapeutics, Inc.
Tristela Capital Partners Announces New Platform Acquisition of Louisiana-Based Pediatric Rural Healthcare Group
Tristela Capital Partners has acquired Pediatric Group of Acadiana and its affiliated management services organization, Independent Physician Services, creating a new healthcare platform focused on expanding pediatric care access and supporting growth across underserved communities in South Central Louisiana. - September 08, 2026 - Tristela Capital Partners
Kepon Biotech Addresses Global Biopharma Supply‑Chain Pain Points with China‑Based One‑Stop Procurement System
Kepon Biotech is a Chinese one‑stop supply‑chain partner for life‑science clients. It resolves procurement challenges: scattered suppliers, complex cross‑border compliance, variable batch quality and long lead‑times. It provides consolidated sourcing, special‑goods compliance, graded cold‑chain logistics and global certifications for cell lines, culture media, LAL reagents and clinical materials, delivering streamlined, low‑risk procurement for pharma, IVD, CRO/CDMO and research institutes. - September 07, 2026 - Shanghai Kepon Biotech Co., Ltd.
Asclepii Selected to Exhibit Poseidon at Vizient Innovative Technology Exchange
Asclepii will showcase its FDA 510(k)-cleared Poseidon™ Nanosilver Hydrogel at Vizient’s Innovative Technology Exchange in Las Vegas on September 24, marking an important milestone in the company’s commercial expansion and bringing its wound care technology to healthcare leaders across Vizient’s network. - September 04, 2026 - Asclepii
Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program
Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. - August 29, 2026 - Helix BioMedix, Inc
VMRD Launches Rapid Horse-Side Insulin Test to Decrease Risk of Laminitis in Metabolic Horses
VMRD, Inc. is thrilled to share the launch of their exciting new test for horse-side measurement of insulin in horses. Run on the same palm-sized reader as VMRD SAA and Foal IgG, this highly portable multi-functional testing platform embodies VMRD’s vision of improving animal health through... - August 28, 2026 - VMRD, Inc.
McObject Announces eXtremeDB 9.0 Featuring Native ANN Indexes and a New Ultra Lightweight Edge Client for IoT
McObject announces eXtremeDB 9.0, a major update to its embedded database system introducing two significant advancements for developers building intelligent, resource constrained systems: native Approximate Nearest Neighbor (ANN) indexes and a new Edge Client requiring as little as 8 KB of... - August 27, 2026 - McObject
The Peptide App Opens Public COA Evidence Index with 5,225 Documents
The Peptide App launched a free public COA Evidence Index containing 5,225 documents, along with a label-first reconstitution calculator. The launch addresses a fast-changing online peptide market: 60 of 82 storefront domains with available registration dates in the app’s current vendor sample were registered in 2024 or later. The index helps people inspect testing records, sources, and limitations without treating a COA as proof of product quality or safety. - August 26, 2026 - The Peptide App
Luminex Wellness & Aesthetics Expands Concierge Perimenopause & Menopause Care with Personalized Hormone Evaluations - Initial Consultation May be Covered by Insurance
New approach focuses on treating women—not just lab results—while helping address common symptoms of perimenopause and menopause. - August 24, 2026 - Luminex Wellness & Aesthetics
Kepon Biotech Launches Integrated Cross‑Border Risk‑Control Solutions for Global Cell Culture Media Trade
Kepon Biotech handles import‑export for fermentation, research and GMP clinical‑grade cell culture media. It addresses cross‑border risks such as bioactivity degradation, complex global regulations and customs detention. With EAC, REACH, FDA, TGA, PMDA, CMDCAS and Halal credentials, it delivers grade classification, global certification, light‑shielded cold‑chain logistics and multilingual customs documents for global CDMOs, biomanufacturers and research labs. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross‑Border Solutions for Global Spermidine Procurement
Kepon Biotech provides multi‑grade spermidine and spermidine trihydrochloride for food, pharma, cosmetics and life‑science research. It mitigates cross‑border risks such as oxidative degradation, complex certification rules and HS misclassification. Backed by EAC, REACH, FDA and Halal credentials, it delivers one‑stop certification, nitrogen‑sealed temperature‑controlled logistics and multilingual customs documents for manufacturers, labs and distributors across EAEU, EU, U.S. and Middle‑East. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches One-Stop Cross-Border Compliance & Logistics Solutions for Life Science Reagents
Kepon Biotech provides a one-stop global compliance and supply system for life science procurement. It solves core cross-border challenges including complex customs clearance, unstable cold-chain logistics, fragmented regional regulations. The company offers standardized biochemical reagents, reference standards and cell culture media, with full compliance support and segmented temperature-controlled logistics, delivering reliable, low-risk sourcing for global labs and pharmaceutical manufacture - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross‑Border Export Solutions for Global LAL Endotoxin‑Testing Reagent Procurement
Kepon Biotech delivers factory‑sourced LAL endotoxin‑testing kits for biopharma, vaccine and medical‑device clients. Working with ISO13485‑certified manufacturers, it provides regional compliance paperwork, 2‑8°C cold‑chain logistics and low‑MOQ trial orders across CIS, Southeast Asia, Middle East, EU and North America. Its one‑stop export solution fixes customs detention, reagent deactivation and raw‑material stock‑out risks for 1000+ users in 50+ countries. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Unveils Full-Link Risk Control & Compliance Solutions for Global Cell Culture Media Trade
Global labs and biopharma firms encounter common cell culture media procurement risks: inconsistent batches, customs delays, cold chain product inactivation and inflexible high MOQs. Shanghai Kepon Biotech releases a full cross-border supply solution and procurement risk guide, offering flexible samples, one-stop biological goods clearance and segmented cryogenic logistics for global cell research, biotech and diagnostic manufacturers. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Comprehensive Cross-Border Procurement & Risk Control Solutions for Industrial Fine Chemicals
Global factories, energy plants and research labs run into widespread procurement risks for industrial chemicals: inconsistent purity, hazardous goods customs blockages, failed long-distance shipping, rigid high MOQs and incomplete compliance documents. Shanghai Kepon Biotech releases an integrated cross-border supply system and complete pitfall guide, providing flexible trial orders, one-stop chemical customs agency and dedicated hazardous cold chain logistics for biotech, pharmaceutical. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross-Border Procurement and Risk Control Solutions for High-Purity Organic & Inorganic Chemicals
Global labs and pharma face organic & inorganic chemical procurement risks including unstable purity, customs detention, failed shipping, high MOQs and incomplete SDS docs. Shanghai Kepon Biotech releases a cross-border supply & risk guide with flexible samples, full chemical clearance and custom cold chain logistics for life science and new energy industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Shanghai Kepon Biotech Launches Full Risk-Control Cross-Border Solutions for Certified Reference Standards Procurement
Global labs, pharma and food testers face China reference standards cross-border risks: poor batch traceability, customs delays, rigid MOQs, cold chain breakdowns and missing COA/SDS. Shanghai Kepon Biotech offers integrated supply, special goods clearance and segmented cold chain for life science, new energy and food testing industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Food Safety Standards Raw Material Procurement Solutions & Risk Avoidance Guide Released by Shanghai Kepon Biotech for Global Food Testing & Food Manufacturing Plants
Global food manufacturers and third-party food testing labs face severe procurement risks for food safety reference standards: inconsistent batch purity, cross-border food regulatory document gaps, strict customs inspection, high MOQ limits and incomplete compliance certification. Shanghai Kepon Biotech launches integrated cross-border supply system, one-stop food safety filing and traceable certified standards for food testing, beverage and food processing industries worldwide. - August 16, 2026 - Shanghai Kepon Biotech Co., Ltd.
Geoprise Announces First-Ever OpenAPI Bridge to Fully Connect ERP and Agentic AI
According to Openapi, Europe’s biggest API Marketplace, no commercial ERP applications expose all their screens, internal functions, and reports as OpenAPI-conforming APIs out of the box. With today’s announcement, GM-X Auto becomes the first and only ERP application in the world to expose all of its 3,871 functions, screens, and reports to Model Context Protocol servers through 456 published APIs compatible with the OpenAPI Specification (OAS). - August 13, 2026 - Geoprise Technologies Corporation
New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors
Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. - August 12, 2026 - Life Science Strategy Group, LLC
DNA Harvest Partners and ToolGen Announce Strategic Partnership to Accelerate AI-Guided Predictive Breeding for Gene-Edited Crops
DNA Harvest Partners Pte. Ltd. (DNAHP), one of the world's most advanced AI-guided predictive breeding companies, and ToolGen, a global leader in CRISPR-Cas9 gene editing technology, today announced a strategic partnership to accelerate the development of superior rapeseed (Brassica napus)... - August 11, 2026 - DNA Harvest Partners Pte. Ltd.
Ferrari and Dr. David Pincus of Pincus Plastic Surgery Unveil a Luxury Lounge Experience at the Hamptons Concours
The roar of rare Ferraris, the unmistakable elegance of the Hamptons, and one of plastic surgery's most recognizable luxury brands came together for an unforgettable weekend at the 2026 Hamptons Concours, produced by luxury event visionary Bradford Rand. Widely regarded as one of the East Coast's... - August 10, 2026 - Pincus Plastic Surgery
ecotera health Submits Decentralized Urine Microplastics / Nanoplastics Observational Study for IRB Review
Study will evaluate an at-home approach to longitudinal microplastics / nanoplastics monitoring in urine using the EcoExposure™ platform - August 08, 2026 - ecotera health
Plastic Surgeon Dr. David Pincus Sponsors the Hamptons Concours d’Elegance Supporting the Southampton Animal Shelter Foundation
Plastic Surgeon Dr. David Pincus and Pincus Plastic Surgery proudly sponsored the 2026 Hamptons Concours d'Elegance, one of the Hamptons' premier luxury charity events, bringing together exotic automobiles, luxury brands, community leaders, and philanthropists for a day dedicated to supporting the... - August 06, 2026 - Pincus Plastic Surgery
Minus K Technology Launches It Educational Giveaway for Universities and Colleges in the USA
Minus K Technology announces its 11th Educational Giveaway of passive mechanical vibration isolators for Universities and Colleges within the USA. Winners get a free brand new negative-stiffness vibration isolator to be used at their school. - August 03, 2026 - Minus K Technology Inc.